Among the carcinogens found in cigarette smoke, NNK [4-(methylnitrosamino)-1-(3-pyridyl)-butanone] is one of the most abundant [2], which leads to K-ras-activating mutations as early events in the pathway leading to lung adenocarcinoma [3,4]. This evidence concerns the gene KRAS and lung adenocarcinoma.